Mergers, Acquisitions and Takeovers Case Study

India’s Jubilant Organosys Acquiring Draxis: An Easy Access to North American Radio Pharmaceutical Market?

OR

Abstract:
Jubilant Organosys Ltd, an integrated pharmaceutical industry player and India's largest custom research and manufacturing company have recently entered into the North American radiopharmaceutical market by acquiring Canada based Draxis Speciality Pharmaceuticals Incorporated. Through this acquisition it wants to tap the lucrative radiopharmaceutical market in North America. This case throws light on the acquisition and its benefits by critically analysing it.

Pedagogical Objectives:

• To the growth strategy of Jubilant
• To Jubilant's acquisition of Draxis and its benefits.

Keywords : Jubilant Organosys, Draxis Health, Radiopharmaceuticals, High entry barrier business, Custom research and manufacturing services (CRAMS), Regulated, Imaging market, International expansion, Acquisition, Pharmaceuticals, Innovator Company, North America

Contents : 
The Global Beer Industry
Sources of Volume Growth between 2006 and 2011
Top 10 Global Brewers, 2005
Market Capitalisation and Valuation Multiples
InBev and Anheuser-Busch: The Merger Deal
Anheuser-Busch’s Domestic Market Share, 2003–2006
InBev’s Beer Sales by Region, 2007
InBev and Anheuser-Busch’s Worldwide Presence
Impact of the Merger